NCT02945059View on ClinicalTrials.gov

Reversible Portal Vein Embolization Before Major Hepatectomy

NACompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

January 15, 2018

Primary Completion Date

April 26, 2022

Study Completion Date

April 26, 2022

Conditions
Liver RegenerationReversible Portal Vein Embolization
Interventions
PROCEDURE

Selective reversible portal vein embolization

Percutaneous access to the portal vein is achieved under general anesthesia with ultrasound or fluoroscopic control. After assessment of portal venous anatomy, embolization of selected portal vein segments is performed using the powdered form of an absorbable gelatin sponge.

Trial Locations (1)

Unknown

Antoine Béclère, Clamart

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT02945059 - Reversible Portal Vein Embolization Before Major Hepatectomy | Biotech Hunter | Biotech Hunter